Descubra el nuevo Chem-Impex: donde la innovación comienza con un vínculo.

Catalog Number:
30803
CAS Number:
82410-32-0
Ganciclovir
Grade:
Meets USP specification
Purity:
≥ 98 % (HPLC)
Synonym(s):
9-(1,3-Dihidroxi-2-propoximetil)guanina, 2-Amino-1,9-dihidro-9-[[2-hidroxi-1-(hidroximetil)etoxi]metil]-6H-purin-6-ona
Documents
$22.03 /1G
Tamaño
Request Bulk Quote
Información del producto

Ganciclovir is an antiviral medication primarily used in the treatment of cytomegalovirus (CMV) infections, particularly in immunocompromised patients such as those undergoing organ transplantation or with HIV/AIDS. This compound acts by inhibiting viral DNA synthesis, making it a crucial therapeutic agent in managing CMV retinitis and preventing CMV disease in at-risk populations. Its effectiveness in reducing viral load and preventing complications associated with CMV infections highlights its importance in clinical settings.

In addition to its primary use, Ganciclovir is also being explored for its potential applications in other viral infections and as a research tool in virology studies. Its unique structure allows for targeted action against viral replication, providing a significant advantage over other antiviral agents. Researchers and healthcare professionals appreciate Ganciclovir for its ability to improve patient outcomes in challenging cases, making it a vital component in antiviral therapy.

Número CAS
82410-32-0
Fórmula molecular
C9H13N5O4
Peso molecular
255.23
Número MDL
MFCD00870588
Punto de fusión
251 - 256 ?C (Lit.)
Condiciones
Conservar entre 0 y 8 °C.
Información general
Número CAS
82410-32-0
Fórmula molecular
C9H13N5O4
Peso molecular
255.23
Número MDL
MFCD00870588
Punto de fusión
251 - 256 ?C (Lit.)
Condiciones
Conservar entre 0 y 8 °C.
Propiedades
¡Pronto habrá más información sobre la propiedad!
-
Seguridad y normativas
Materiales peligrosos
-
Antibiótico
-
Regulado por la DEA
No
Advertencias
-
Aplicaciones

Ganciclovir is widely utilized in research focused on:

  • Antiviral Treatments: Primarily used in the treatment of cytomegalovirus (CMV) infections, especially in immunocompromised patients, such as those undergoing organ transplants or with HIV/AIDS.
  • Research in Viral Pathogenesis: Employed in laboratory studies to understand the mechanisms of CMV and other herpesviruses, aiding in the development of new antiviral therapies.
  • Pharmaceutical Development: Acts as a key compound in the formulation of antiviral medications, allowing researchers to explore combination therapies that enhance efficacy against resistant viral strains.
  • Diagnostic Applications: Utilized in the development of diagnostic tests for CMV, helping healthcare professionals to quickly identify infections and tailor treatment plans.
  • Gene Therapy Research: Investigated for its potential in gene therapy applications, where it may be used to deliver therapeutic genes to target cells, enhancing treatment options for various genetic disorders.

Citas